Symbol
| EIF4EBP1
| contributors: mct/npt - updated : 20-10-2017
|
HGNC name
| eukaryotic translation initiation factor 4E binding protein 1
|
HGNC id
| 3288
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
hyperphosphorylated in some cancers | tumoral
|  
|  
|  
|  
|
phosphorylated EIF4EBP1 expression in endometrial cancer correlates with aggressive tumors and prognosis (Castellvi 2009) | tumoral
|  
|  
| --over
|  
|
upregulation in eutopic endometrium may be associated with the pathogenesis of endometriosis (Laudanski 2009) | |
Variant & Polymorphism
|
| |
Candidate gene
| expression of mTOR and EIF4EBP1 characterize high-grade, high-stage endometrial adenocarcinomas and might be predictive markers of a response to rapamycin (Darb-Esfahani 2009) |
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | | | |
for cancer therapy, potentially (small-molecule inhibitors that pharmacologically mimic function) | cancer | skin | | |
phosphorylated EIF4EBP1 is associated with poor survival in melanoma and effective inhibition of the pathways responsible for EIF4EBP1 phosphorylation should be considered to improve the treatment outcome of metastatic melanoma patients |
| | |
| elevated Eif4ebp1 expression observed in the retina of diabetic rodents is the result of O-GlcNAcylation of Eif4ebp1 within its PEST motif |